Zobrazeno 1 - 10
of 461
pro vyhledávání: '"A. Beiderbeck"'
Autor:
Mariani, Arturo, Senocrate, Federico, Mikiel-Hunter, Jason, McAlpine, David, Beiderbeck, Barbara, Pecka, Michael, Lin, Kevin, Kreuz, Thomas
Background: In Kreuz et al., J Neurosci Methods 381, 109703 (2022) two methods were proposed that perform latency correction, i.e., optimize the spike time alignment of sparse neuronal spike trains with well defined global spiking events. The first o
Externí odkaz:
http://arxiv.org/abs/2410.15018
Publikováno v:
In Technological Forecasting & Social Change November 2024 208
Publikováno v:
In Technological Forecasting & Social Change June 2024 203
Publikováno v:
In Technological Forecasting & Social Change February 2023 187
Publikováno v:
In Technological Forecasting & Social Change September 2022 182
Autor:
Carboni, Lucia, El Khoury, Aram, Beiderbeck, Daniela I., Neumann, Inga D., Mathé, Aleksander A.
Publikováno v:
In European Neuropsychopharmacology April 2022 57:1-14
Autor:
Michaela Müller, Hongmei Hu, Mathias Dietz, Barbara Beiderbeck, Dardo N. Ferreiro, Michael Pecka
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2023)
The ability to localize a sound source in complex environments is essential for communication and navigation. Spatial hearing relies predominantly on the comparison of differences in the arrival time of sound between the two ears, the interaural time
Externí odkaz:
https://doaj.org/article/ef941af3b3d043d3af3d939b83464c67
Autor:
Beiderbeck, Daniel, Frevel, Nicolas, von der Gracht, Heiko A., Schmidt, Sascha L., Schweitzer, Vera M.
Publikováno v:
In Technological Forecasting & Social Change April 2021 165
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background Diabetic macular oedema (DMO) may lead to visual loss and blindness. Several pharmacological treatments are available on the National Health Service (NHS) to United Kingdom patients affected by this condition, including intravitre
Externí odkaz:
https://doaj.org/article/974805edcdf54056967f31058fcffe78